ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2016

Abstract Number: 2951

Patient Outcomes in Primary Angiitis of the Central Nervous System

Elisabeth Ray1, Didem Saygin2, Anabelle Morales-Mena3, William Messner4, Leonard H. Calabrese5 and Rula A Hajj-Ali6, 1Rheumatology, Cleveland Clinic, Cleveland, OH, 2Cleveland Clinic, Cleveland, OH, 3Rheumatology, Hillcrest Hospital, Mayfield Heights, OH, 4Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, 5Rheumatic & Immunologic Disease, Cleveland Clinic, Cleveland, OH, 6Rheumatic and Immunologic Dis, Cleveland Clinic, Cleveland, OH

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2016

Date of first publication: September 28, 2016

Keywords: central nervous system involvement, CNS Vasculitis, outcomes and polyangiitis

Session Information

Date: Tuesday, November 15, 2016

Title: Vasculitis - Poster III: Rarer Vasculitides

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Primary angiitis of the CNS (PACNS) is a rare form of vasculitis confined to the brain and spinal cord, which often presents with severe cognitive and functional deficits.  Although we have witnessed a tremendous progress in the recognition and diagnosis of this disease, there is still little known about the quality of life that these patients have following a diagnosis of PACNS. The aim of this study is 1) to evaluate patients’ functional capabilities, quality of life, and frequency of depression after being diagnosed and treated for PACNS; and 2) to determine the effect of treatment duration on patient outcomes.

Methods: This is a cross-sectional study from a tertiary referral center. Eligible patient records were identified via retrospective chart review using the ICD-9 code for cerebral angiitis. Patients were included if they met 2 of the 3 following criteria: inflammatory CSF, angiogram typical of vasculitis, or vasculitis present on pathology of the brain. In addition, the diagnosis of PACNS was further agreed upon by 2 rheumatologists in the department who have particular expertise in this disease. Self-reported questionnaires were prospectively collected from eligible subjects. Measure of disability was assessed by the Barthel Index (BI), quality of life was assessed by EuroQOL (EQ-5D-5L), and depression was assessed with Patient Health Questionnaire (PHQ-9). Treatment history was collected from patient report and chart review.

Results: 1855 patient records were identified using the ICD-9 code for cerebral angiitis. 78 patients met inclusion criteria, of which 27 responded to the questionnaires (34.6%). Median follow-up of those who responded was 5.5 years (+/- 4.7 years) since diagnosis of PACNS. Using the Barthel Index scale, 19 of 27 patients (70.4%) scored 85 or more, indicating mild disability. Meanwhile, five (18.5%) patients scored 25 or less, indicating severe disability. Using the EQ-5D-5L questionnaire, 14 of 27 patients (51.9%) had no problems with mobility, 18 (66.7%) had no problems with self-care, 15 (55.6%) had no problems with usual activities, and 14 (51.9%) had no problems with pain, but only 8 (29.6%) had no problems with anxiety. Approximately 70% of patients had minimal or no depression using both the PHQ-9 scale and EuroQOL. There was a slight positive relationship between several of the outcome measures and duration of immunosuppressive therapy, although it is not statistically significant.  

Conclusion: This is the longest reported follow-up of patients with PACNS described in the literature to-date. Most patients have mild long-term disability and minimal to no depression, which may be reflective of the advances of treatment. The data shows a slight tendency towards better scores being associated with longer treatments. However, larger studies are needed to verify the extent and strength of these relationships.


Disclosure: E. Ray, None; D. Saygin, None; A. Morales-Mena, None; W. Messner, None; L. H. Calabrese, None; R. A. Hajj-Ali, None.

To cite this abstract in AMA style:

Ray E, Saygin D, Morales-Mena A, Messner W, Calabrese LH, Hajj-Ali RA. Patient Outcomes in Primary Angiitis of the Central Nervous System [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/patient-outcomes-in-primary-angiitis-of-the-central-nervous-system/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-outcomes-in-primary-angiitis-of-the-central-nervous-system/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology